Celldex Therapeutics Correlations
CLDX Stock | USD 26.58 0.36 1.37% |
The current 90-days correlation between Celldex Therapeutics and Ideaya Biosciences is 0.24 (i.e., Modest diversification). The correlation of Celldex Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Celldex Therapeutics Correlation With Market
Weak diversification
The correlation between Celldex Therapeutics and DJI is 0.3 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Celldex Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Celldex |
Moving together with Celldex Stock
0.72 | ME | 23Andme Holding | PairCorr |
0.74 | VALN | Valneva SE ADR | PairCorr |
0.75 | VCNX | Vaccinex | PairCorr |
0.73 | DRMA | Dermata Therapeutics | PairCorr |
0.81 | DTIL | Precision BioSciences | PairCorr |
0.87 | VINC | Vincerx Pharma | PairCorr |
0.7 | VRAX | Virax Biolabs Group | PairCorr |
0.83 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.7 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.62 | VTGN | VistaGen Therapeutics | PairCorr |
Moving against Celldex Stock
0.78 | DRUG | Bright Minds Biosciences | PairCorr |
0.69 | SABSW | SAB Biotherapeutics | PairCorr |
0.61 | VCYT | Veracyte | PairCorr |
0.61 | VERA | Vera Therapeutics | PairCorr |
0.36 | DMAC | DiaMedica Therapeutics | PairCorr |
0.36 | VANI | Vivani Medical | PairCorr |
0.35 | DSGN | Design Therapeutics | PairCorr |
0.82 | VRNA | Verona Pharma PLC | PairCorr |
0.71 | VSTM | Verastem Trending | PairCorr |
0.56 | VRDN | Viridian Therapeutics | PairCorr |
0.5 | DVAX | Dynavax Technologies | PairCorr |
0.48 | VTRS | Viatris | PairCorr |
0.37 | KTTAW | Pasithea Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Celldex Stock performing well and Celldex Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Celldex Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
IDYA | 2.25 | (0.73) | 0.00 | (0.35) | 0.00 | 4.15 | 15.21 | |||
ANAB | 3.55 | (1.02) | 0.00 | (0.21) | 0.00 | 5.77 | 35.57 | |||
MGTX | 2.78 | 0.51 | 0.19 | 0.36 | 2.71 | 6.75 | 21.07 | |||
KROS | 2.27 | 0.38 | 0.16 | 0.39 | 2.19 | 5.38 | 16.94 | |||
FIXX | 2.82 | 0.07 | 0.01 | 0.20 | 3.52 | 5.77 | 19.43 | |||
CERE | 0.77 | 0.09 | (0.03) | (0.59) | 0.94 | 1.91 | 6.40 | |||
RNA | 3.01 | (0.31) | 0.00 | (0.07) | 0.00 | 5.78 | 27.94 | |||
RVMD | 2.20 | 0.09 | 0.04 | 0.17 | 3.03 | 4.81 | 16.40 | |||
DAWN | 2.04 | (0.09) | (0.04) | (0.01) | 2.71 | 3.84 | 11.44 | |||
SWTX | 2.14 | (0.02) | (0.02) | 0.08 | 2.70 | 4.86 | 12.80 |
Celldex Therapeutics Corporate Management
Ronald Pepin | Chief Bus. Officer and Sr. VP | Profile | |
Patrick Till | Senior Communications | Profile | |
Prof Schlessinger | CoFounder Board | Profile | |
Diane MD | Senior Officer | Profile | |
Margo MD | Senior Affairs | Profile |